Q1 2017
Released May 9, 2017, before the open
10-Q filed May 9, 2017, 39 days after period end · 0001493152-17-004892
Q1 2017 · 10-Q
Revenue$734.00K$734.00K +24.4% vs Q1 2016−1.6% vs Q4 2016
Net Income-$680.00K-$680.00K N/M vs Q1 2016N/M vs Q4 2016
EPS Diluted-$0.01-$0.01 N/M vs Q1 2016no prior Q4 2016 on file
Gross Profit$455,000+54.2%
Operating Income-$605,000N/M
Operating Cash Flow-$659,000N/M
Margins · derived
Gross margin62.0%+12.0 pt vs Q1 2016
Operating margin-82.4%+54.2 pt vs Q1 2016
Net margin-92.6%+49.1 pt vs Q1 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $734.00K | $590.00K | $544.00K | $473.00K |
| Net Income | -$680.00K | -$836.00K | $243.00K | -$3.51M |
| EPS Diluted | -$0.01 | -$0.02 | -$0.02 | -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR